ZA95638B - Oral administration form having acid active substances and a process for its production - Google Patents

Oral administration form having acid active substances and a process for its production

Info

Publication number
ZA95638B
ZA95638B ZA95638A ZA95638A ZA95638B ZA 95638 B ZA95638 B ZA 95638B ZA 95638 A ZA95638 A ZA 95638A ZA 95638 A ZA95638 A ZA 95638A ZA 95638 B ZA95638 B ZA 95638B
Authority
ZA
South Africa
Prior art keywords
pct
oral administration
active substances
administration form
production
Prior art date
Application number
ZA95638A
Other languages
English (en)
Inventor
Walter Mueller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA95638B publication Critical patent/ZA95638B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
ZA95638A 1994-01-27 1995-01-26 Oral administration form having acid active substances and a process for its production ZA95638B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ZA95638B true ZA95638B (en) 1995-10-25

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95638A ZA95638B (en) 1994-01-27 1995-01-26 Oral administration form having acid active substances and a process for its production

Country Status (22)

Country Link
US (1) US5858344A (xx)
EP (1) EP0741574B1 (xx)
JP (1) JP3701971B2 (xx)
KR (1) KR100439311B1 (xx)
AT (1) ATE218371T1 (xx)
AU (1) AU697353B2 (xx)
CA (1) CA2182417C (xx)
CZ (1) CZ291006B6 (xx)
DE (2) DE4402379C2 (xx)
DK (1) DK0741574T3 (xx)
ES (1) ES2177622T3 (xx)
FI (1) FI116880B (xx)
HU (1) HU223317B1 (xx)
IL (1) IL112435A (xx)
MY (1) MY113340A (xx)
NO (1) NO963143L (xx)
NZ (1) NZ277777A (xx)
PL (1) PL315619A1 (xx)
PT (1) PT741574E (xx)
SK (1) SK97296A3 (xx)
WO (1) WO1995020394A1 (xx)
ZA (1) ZA95638B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
CA2938564C (en) 2006-11-07 2017-04-11 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2022259848A1 (ja) 2021-06-07 2022-12-15 国立大学法人筑波大学 高分子化バルプロ酸及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
DE4402379A1 (de) 1995-08-03
JP3701971B2 (ja) 2005-10-05
AU1312795A (en) 1995-08-15
DE59410133D1 (de) 2002-07-11
FI962985A (fi) 1996-07-26
CA2182417A1 (en) 1995-08-03
HU9602041D0 (en) 1996-09-30
HU223317B1 (hu) 2004-05-28
PT741574E (pt) 2002-11-29
DK0741574T3 (da) 2002-09-23
FI962985A0 (fi) 1996-07-26
CZ291006B6 (cs) 2002-11-13
PL315619A1 (en) 1996-11-25
CZ221396A3 (en) 1997-01-15
IL112435A (en) 1999-01-26
WO1995020394A1 (de) 1995-08-03
AU697353B2 (en) 1998-10-01
KR970700505A (ko) 1997-02-12
JPH09511488A (ja) 1997-11-18
ATE218371T1 (de) 2002-06-15
EP0741574A1 (de) 1996-11-13
IL112435A0 (en) 1995-03-30
NZ277777A (en) 1997-01-29
US5858344A (en) 1999-01-12
DE4402379C2 (de) 1997-09-25
ES2177622T3 (es) 2002-12-16
MY113340A (en) 2002-01-31
FI116880B (fi) 2006-03-31
NO963143D0 (no) 1996-07-26
SK97296A3 (en) 1997-04-09
KR100439311B1 (ko) 2005-08-17
CA2182417C (en) 2007-04-17
NO963143L (no) 1996-09-24
HUT74434A (en) 1996-12-30
EP0741574B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
MX9606744A (es) Acidos hidroxamicos sustituidos por sulfonamido arilico como inhibidores de metaloproteinasa de matriz.
BG101781A (en) Active substance-containing solid preparation
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
NZ510254A (en) Novel composition and use
AU2705588A (en) New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use.
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
IL113450A (en) Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby
ZA964035B (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ZA95638B (en) Oral administration form having acid active substances and a process for its production
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
HUT69372A (en) Diamine salts of clarulanic acid, pharmaceutical compositions containing the same and process for their production
AU7706394A (en) Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
EP0362941A3 (en) 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones
GEP20022652B (en) ) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
HK1025558A1 (en) Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
FR2652590B1 (fr) Exopolymere extracellulaire, son procede de preparation et compositions pharmaceutiques le contenant.
MX9700421A (es) Tienil- y furanil- oxazolidinonas piridocondensadas.
PL322847A1 (en) Condensed b-carbolins
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь